Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Explore the Relationship Between Single Nucleotide Polymorphisms and Abiraterone Response and Toxicity in Patients With Prostate Cancer.

NCT03348670 is registered in ClinicalTrials.gov with Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair as lead sponsor.

NCT NCT03348670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03348670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Explore the Relationship Between Single Nucleotide Polymorphisms and Abiraterone Response and Toxicity in Patients With Prostate Cancer.
Lead sponsor
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
August 18, 2023
Completion date
December 28, 2026
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer